CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), 13986-13987 [2018-06547]
Download as PDF
<![CDATA[
13986
Federal Register / Vol. 83, No. 63 / Monday, April 2, 2018 / Notices
to seek court review of the
Commission’s final order.
The Commission strongly encourages
electronic filings of comments, protests
and interventions in lieu of paper using
the ‘‘eFiling’’ link at https://
www.ferc.gov. Persons unable to file
electronically should submit an original
and 5 copies of the protest or
intervention to the Federal Energy
Regulatory Commission, 888 First Street
NE, Washington, DC 20426.
Comment Date: 5:00 p.m. Eastern
Time on April 17, 2018.
Dated: March 27, 2018.
Kimberly D. Bose,
Secretary.
BILLING CODE 6717–01–P
FEDERAL RESERVE SYSTEM
daltland on DSKBBV9HB2PROD with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than April 30, 2018.
A. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
1. TYME Bancshares, Inc., Dallas,
Texas; to become a bank holding
19:06 Mar 30, 2018
Board of Governors of the Federal Reserve
System, March 28, 2018.
Ann Misback,
Secretary of the Board.
[FR Doc. 2018–06602 Filed 3–30–18; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
Notice of Proposals To Engage in or to
Acquire Companies Engaged in
Permissible Nonbanking Activities
[FR Doc. 2018–06648 Filed 3–30–18; 8:45 am]
VerDate Sep<11>2014
company by acquiring 100 percent of
Groom Bancshares, Inc., and therefore
indirectly acquire The State National
Bank, both of Groom, Texas.
Jkt 244001
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than April 17, 2018.
A. Federal Reserve Bank of Richmond
(Adam M. Drimer, Assistant Vice
President) 701 East Byrd Street,
Richmond, Virginia 23219. Comments
can also be sent electronically to or
Comments.applications@rich.frb.org:
1. First Bankshares, Inc.,
Barboursville, West Virginia; to engage
through a subsidiary, Community
Mortgage Network, Inc., Huntington,
West Virginia, in extending credit and
servicing loans pursuant to section
225.28(b)(1) of Regulation Y.
Board of Governors of the Federal Reserve
System, March 28, 2018.
Ann Misback,
Secretary of the Board.
[FR Doc. 2018–06601 Filed 3–30–18; 8:45 am]
BILLING CODE P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment (CHACHSPT)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC and the Health Resources and
Services Administration (HRSA),
announce the following meeting for the
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment (CHACHSPT). This
meeting is open to the public, limited
only by 100 room seating and 100 ports
for audio phone lines. Time will be
available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipts
is Monday, May 7, 2018. Persons who
desire to make an oral statement, may
request it at the time of the public
comments period on May 9, 2018 at 4:15
p.m. EDT. This meeting is accessible by
web conference: 1–877–603–4228,
Participant code: 42598858.
DATES: The meeting will be held on May
9, 2018, 8:30 a.m. to 5:00 p.m., EDT and
May 10, 2018, 8:30 a.m. to 12:00 p.m.,
EDT.
ADDRESSES: CDC Corporate Square,
Building 8, Conference Room 1–ABC, 8
Corporate Boulevard, Atlanta, Georgia
30329.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE, Mailstop: E–07,
Atlanta, Georgia 30333, telephone (404)
639–8317; zkr7@cdc.gov
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with advising the Director, CDC and the
Administrator, HRSA, regarding
activities related to prevention and
control of HIV/AIDS, Viral Hepatitis and
other STDs, the support of health care
services to persons living with HIV/
AIDS, and education of health
professionals and the public about HIV/
AIDS, Viral Hepatitis and other STDs.
Matters To Be Considered: The agenda
will include discussions on (1) HIV,
Viral Hepatitis, and Sexually
Transmitted Disease consequences of
E:\FR\FM\02APN1.SGM
02APN1
Federal Register / Vol. 83, No. 63 / Monday, April 2, 2018 / Notices
the opioid crisis; (2) Perspectives on,
and experiences with, syringe services
program (SSP); (3) Continued discussion
on HIV transmission risk in the context
of Antiretroviral Therapy (ART) use and
Viral Suppression (Treatment as
Prevention or TasP); (4) Anti-bullying
policies in schools; and (5) Updates
from Workgroups. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–06547 Filed 3–30–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Office of Infectious Diseases (BSC, OID).
This meeting is open to the public,
limited only by the space available; the
meeting room will accommodate up to
100 people. The public is also welcome
to listen to the meeting by telephone,
limited only by the number of ports
available (50); the toll-free dial-in
number is 1–888–998–7892, with a pass
code of 1252535.
DATES: The meeting will be held on May
2, 2018, 8:30 a.m. to 5:00 p.m., EDT, and
May 3, 2018, 8:30 a.m. to 12:00 p.m.,
EDT.
SUMMARY:
CDC, Global
Communications Center, 1600 Clifton
Road NE, Building 19, Auditorium B1/
B2, Atlanta, Georgia 30329; also 1–888–
998–7892.
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, MPH, Designated Federal
Officer, OID, CDC, 1600 Clifton Road
NE, Mailstop D10, Atlanta, Georgia
daltland on DSKBBV9HB2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
19:06 Mar 30, 2018
Jkt 244001
30329, Telephone (404) 639–4840;
sed5@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters To Be Considered: The agenda
will include discussions on priority
issues for the national centers, including
influenza, foodborne infections,
antimicrobial resistance, and viral
hepatitis, as well as public health
workforce development. A report back
from the Board’s Infectious Disease
Laboratory Working Group will also be
given. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–06545 Filed 3–30–18; 8:45 am]
BILLING CODE 4163–19–P
13987
only by the room seating. The meeting
room accommodates up to 80 people.
Public participants should pre-register
for the meeting as described below.
Members of the public that wish to
attend this meeting in person should
pre-register by submitting the following
information by email, facsimile, or
phone (see Contact Person for More
Information) no later than 12:00 noon
(EDT) on Wednesday, May 2, 2018:
• Full Name
• Organizational Affiliation
• Complete Mailing Address
• Citizenship
• Phone Number or Email Address
The public is also welcome to listen
to the meeting by via Adobe Connect.
Pre-registration is required by clicking
the links below.
WEB ID: May 9, 2018 (100 Seats)
https://adobeconnect.cdc.gov/
e9teo9x7k41/event/registration.html.
WEB ID: May 10, 2018 (100 Seats)
https://adobeconnect.cdc.gov/
e2jt3r7tvlj/event/registration.html.
Dial in number: 800–857–9618;
Participant code: 6838980. (100 Seats).
DATES: The meeting will be held on May
9, 2018, 10:00 a.m.–5:30 p.m., EDT and
May 10, 2018, 8:30 a.m.–3:30 p.m., EDT.
ADDRESSES: Centers for Disease Control
and Prevention (CDC), Global
Communications Center, Building 19,
Auditorium B3, 1600 Clifton Road NE,
Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop D–44,
Atlanta, Georgia 30329, Telephone:
(404) 639–7450; Facsimile: (404) 471–
8772; Email: OPHPR.BSC.Questions@
cdc.gov.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response, (BSC, OPHPR)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
Office of Public Health Preparedness
and Response, (BSC, OPHPR). This
meeting is open to the public, limited
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Office of Public Health Preparedness
and Response (OPHPR), concerning
strategies and goals for the programs
and research within OPHPR, monitoring
the overall strategic direction and focus
of the OPHPR Divisions and Offices,
and administration and oversight of
peer review for OPHPR scientific
programs. For additional information
about the Board, please visit: https://
www.cdc.gov/phpr/science/
counselors.htm.
Matters To Be Considered: The agenda
will include discussions on Day one of
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 83, Number 63 (Monday, April 2, 2018)]
[Notices]
[Pages 13986-13987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06547]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHACHSPT)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
and the Health Resources and Services Administration (HRSA), announce
the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment (CHACHSPT). This meeting is
open to the public, limited only by 100 room seating and 100 ports for
audio phone lines. Time will be available for public comment. The
public is welcome to submit written comments in advance of the meeting.
Comments should be submitted in writing by email to the contact person
listed below. The deadline for receipts is Monday, May 7, 2018. Persons
who desire to make an oral statement, may request it at the time of the
public comments period on May 9, 2018 at 4:15 p.m. EDT. This meeting is
accessible by web conference: 1-877-603-4228, Participant code:
42598858.
DATES: The meeting will be held on May 9, 2018, 8:30 a.m. to 5:00 p.m.,
EDT and May 10, 2018, 8:30 a.m. to 12:00 p.m., EDT.
ADDRESSES: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8
Corporate Boulevard, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07,
Atlanta, Georgia 30333, telephone (404) 639-8317; [email protected]
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged with advising the Director, CDC
and the Administrator, HRSA, regarding activities related to prevention
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of
health care services to persons living with HIV/AIDS, and education of
health professionals and the public about HIV/AIDS, Viral Hepatitis and
other STDs.
Matters To Be Considered: The agenda will include discussions on
(1) HIV, Viral Hepatitis, and Sexually Transmitted Disease consequences
of
[[Page 13987]]
the opioid crisis; (2) Perspectives on, and experiences with, syringe
services program (SSP); (3) Continued discussion on HIV transmission
risk in the context of Antiretroviral Therapy (ART) use and Viral
Suppression (Treatment as Prevention or TasP); (4) Anti-bullying
policies in schools; and (5) Updates from Workgroups. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-06547 Filed 3-30-18; 8:45 am]
BILLING CODE 4163-19-P
